Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up ...

The concerns surrounding Zantac also prompted UK health authorities to advise doctors in 2019 to cease prescribing specific formulations of the drug as a precautionary measure. Reports indicated that ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a ...

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

(Reuters) - GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ...

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

"I've watched and been a part of Illumina growing from a startup to one of the most important and innovative companies in the ...